2-propylpyrrolidin-1-ium;chloride

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: 2-propylpyrrolidin-1-ium;chloride
• 化学式: C7H16ClN
• 分子量: 149.66
• InChiKey: JIXMHDUHJCUGRR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.96
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12
• 氢给体数：
  2
• 氢受体数：
  1

文献信息

• Inhibitors of cytosolic phospholipase A2
  申请人：Wyeth

  公开号：US20030144282A1

  公开（公告）日：2003-07-31

  This invention provides substituted indole compounds of the general formula: 1 and pharmaceutically acceptable salt forms thereof, and methods for using the compounds as inhibitors of the activity of various phospholipase enzymes, particularly phospholipase A 2 enzymes, and for the medical treatment, prevention and inhibition of pain and inflammation.

  这项发明提供了一般式如下的取代吲哚化合物： 1 及其药用可接受的盐形式，以及将这些化合物用作各种磷脂酶酶的抑制剂的方法，特别是磷脂酶A 2 酶，并用于医疗治疗、预防和抑制疼痛和炎症。
• Methods for the use of inhibitors of cytosolic phospholipase A2 in the treatment of thrombosis
  申请人：Clerin Valerie

  公开号：US20080009485A1

  公开（公告）日：2008-01-10

  This invention provides methods for the use of substituted indole compounds of the general formula: and pharmaceutically acceptable salt forms thereof. The invention provides methods for the use of the compounds in the treating or preventing thrombosis in a mammal, or preventing progression of symptoms of thrombosis.

  这项发明提供了一种使用通式所示的取代吲哚化合物及其药用盐形式的方法。该发明提供了一种在哺乳动物中治疗或预防血栓形成，或预防血栓形成症状进展的化合物使用方法。
• Chiral pyrrolidine derivatives, and methods for preparing compounds thereof
  申请人：Whitten P. Jeffrey

  公开号：US20060025468A1

  公开（公告）日：2006-02-02

  The present invention relates to chiral pyrrolidine derivatives; and methods for preparing compounds thereof. The chiral pyrrolidine derivatives of the present invention may be used as intermediates for pharmaceutical and agricultural chemicals.

  本发明涉及手性吡咯烷衍生物，以及制备其化合物的方法。本发明的手性吡咯烷衍生物可用作制药和农业化学品的中间体。
• Methods for treating arthritic disorders
  申请人：Wyeth

  公开号：US20030166649A1

  公开（公告）日：2003-09-04

  This invention provides methods for treating in mammals arthritic or rheumatic disorders using substituted indole compounds of the general formula: 1 and pharmaceutically acceptable salt forms thereof, and methods for using the compounds as inhibitors of the activity of various phospholipase enzymes, particularly phospholipase A 2 enzymes, and for the medical treatment, prevention and inhibition of pain and inflammation.

  本发明提供了一种使用一般式（1）的取代吲哚化合物及其药学上可接受的盐形式来治疗哺乳动物的关节炎或风湿性疾病的方法，以及使用这些化合物作为各种磷脂酶酶活性抑制剂，特别是磷脂酶A2酶的抑制剂的方法，并用于医疗治疗、预防和抑制疼痛和炎症。
• Methods for the use of inhibitors of cytosolic phospholipase A2
  申请人：McKew C. John

  公开号：US20060014759A1

  公开（公告）日：2006-01-19

  This invention provides methods for the use of substituted indole compounds of the general formula: and pharmaceutically acceptable salt forms thereof. The invention provides methods for the use of the compounds as inhibitors of the activity of various phospholipase enzymes, particularly phospholipase A 2 enzymes, and for the medical treatment, prevention and inhibition diseases and disorders including asthma, stroke, atherosclerosis, multiple sclerosis, Parkinson's disease, arthritic disorders, rheumatic disorders, central nervous system damage resulting from stroke, central nervous system damage resulting from ischemia, central nervous system damage resulting from trauma, inflammation caused or potentiated by prostaglandins, inflammation caused or potentiated by leukotrienes, inflammation caused or potentiated by platelet activation factor, pain caused or potentiated by prostaglandins, pain caused or potentiated by leukotrienes, and pain caused or potentiated by platelet activation factor.

  这项发明提供了使用一般式为的取代吲哚化合物及其药学上可接受的盐形式的方法。该发明提供了将该化合物用作各种磷脂酶酶活性抑制剂的方法，特别是磷脂酶A2酶，并用于医疗治疗、预防和抑制哮喘、中风、动脉粥样硬化、多发性硬化症、帕金森病、关节炎性疾病、风湿性疾病、中风引起的中枢神经系统损伤、缺血引起的中枢神经系统损伤、创伤引起的中枢神经系统损伤、由前列腺素引起或增强的炎症、由白三烯引起或增强的炎症、由血小板活化因子引起或增强的炎症、由前列腺素引起或增强的疼痛、由白三烯引起或增强的疼痛和由血小板活化因子引起或增强的疼痛的疾病和疾患的方法。